Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas
- PMID: 15720432
- PMCID: PMC1782085
- DOI: 10.1111/j.1365-2567.2005.02091.x
Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas
Abstract
Interaction of cytokines with their cognate receptors leads to the activation of latent transcription factors - the signal transducers and activators of transcription (STAT) proteins - whose biological activities ultimately regulate many critical aspects of cell growth, survival and differentiation. Dysregulation of the JAK-STAT pathway is frequently observed in many primary human tumours, reflecting the importance of this pathway in the maintenance of cellular integrity. Here we review the current progress in STAT structure and function, and the contribution of STAT signalling to the pathogenesis of T-cell lymphomas.
Figures



Similar articles
-
JAK/STAT-dependent gene regulation by cytokines.Drug News Perspect. 2005 May;18(4):243-9. doi: 10.1358/dnp.2005.18.4.908658. Drug News Perspect. 2005. PMID: 16034480 Review.
-
STAT proteins as novel targets for cancer drug discovery.Expert Opin Ther Targets. 2004 Oct;8(5):409-22. doi: 10.1517/14728222.8.5.409. Expert Opin Ther Targets. 2004. PMID: 15469392 Review.
-
Cytokines and STAT signaling.Adv Pharmacol. 2000;47:113-74. doi: 10.1016/s1054-3589(08)60111-8. Adv Pharmacol. 2000. PMID: 10582086 Review. No abstract available.
-
Role of Jak kinases and STATs in cytokine signal transduction.Int J Hematol. 2001 Apr;73(3):271-7. doi: 10.1007/BF02981951. Int J Hematol. 2001. PMID: 11345192 Review.
-
Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.Cell Growth Differ. 2001 Mar;12(3):169-74. Cell Growth Differ. 2001. PMID: 11306517
Cited by
-
FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation.Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):584-594. doi: 10.1073/pnas.1909879116. Epub 2019 Dec 16. Proc Natl Acad Sci U S A. 2020. PMID: 31843895 Free PMC article.
-
Mechanism of the JAK2/STAT3-CAV-1-NR2B signaling pathway in painful diabetic neuropathy.Endocrine. 2019 Apr;64(1):55-66. doi: 10.1007/s12020-019-01880-6. Epub 2019 Mar 4. Endocrine. 2019. PMID: 30830585 Free PMC article.
-
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.Invest New Drugs. 2010 Dec;28 Suppl 1(Suppl 1):S3-20. doi: 10.1007/s10637-010-9596-y. Epub 2010 Dec 14. Invest New Drugs. 2010. PMID: 21161327 Free PMC article. Review.
-
The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs.Biology (Basel). 2015 Jul 28;4(3):494-511. doi: 10.3390/biology4030494. Biology (Basel). 2015. PMID: 26226008 Free PMC article. Review.
-
Lithocholic Acid Induces miR21, Promoting PTEN Inhibition via STAT3 and ERK-1/2 Signaling in Colorectal Cancer Cells.Int J Mol Sci. 2021 Sep 22;22(19):10209. doi: 10.3390/ijms221910209. Int J Mol Sci. 2021. PMID: 34638550 Free PMC article.
References
-
- Darnell JE, Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415. - PubMed
-
- Gadina M, Hilton D, Johnston JA, Morinobu A, Lighvani A, Zhou YJ, Visconti R, O'Shea JJ. Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol. 2001;13:363. - PubMed
-
- Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene. 2000;19:2474. - PubMed
-
- Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol. 2003;197:157. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous